Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5857 posts found.

Bayer’s Nubeqa combo approved in Europe for non-metastatic castration-resistant prostate cancer

March 31, 2020 Manufacturing and Production, Research and Development Bayer, Cancer, Europe, Nubeqa, prostate cancer

The European Commission has given the green light to Bayer’s non-steroidal androgen receptor inhibitor Nubeqa (darolutamide), jointly developed with Orion, …
News
000_parliiii

UK social distancing measures making a difference to the spread of COVID-19, government says

March 31, 2020 Manufacturing and Production British Coronavirus, COVID-`9, coronavirus, coronavirus uk

Social distancing measures are slowing down the spread of coronavirus and keeping pressure off the NHS, according to the UK’s …
News
shutterstock_212432119

EUSA Pharma and Ergomed partner to investigate IL-6 targeting in COVID-19 patients with serious respiratory complications

March 31, 2020 Manufacturing and Production, Research and Development COVID-19, Eusa Pharma, coronavirus, ergomed, pharma

Oncology and rare disease firm EUSA Pharma is aiding in the global fight against the novel coronavirus with the launch …
News
medications-257333_640

People or profit: What is the best system to regulate drug prices?

March 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Conor Kavanagh investigates the role state healthcare institutions play in negotiating drug prices, and what steps can be taken for …
Feature
gary-jacob-cropped

Immunron Chief Executive Officer Gary Jacob resigns amidst coronavirus cost-cutting

March 27, 2020 Manufacturing and Production

The Chief Executive Officer of Immuron, Gary S. Jacob, has resigned as CEO and as a member of the Board …
Appointment
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 27, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

The COVID-19 global pandemic continues to dominate the news cycle. The first clinical trial using danoprevir (Ganovo) in treating COVID-19 …
News

Roche shows improved survival rates in new treatment for untreated acute myeloid leukaemia

March 24, 2020 Manufacturing and Production Cancer, Roche, acute myeloid leukamia

Roche has announced that its clinical trials for Venclexta/Venclyzto combination with azacitidine have met its primary endpoints of overall survival …
News
screen_shot_2020-01-29_at_16

Sustainability and security: How packaging is modernising pharma

March 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing counterfeit medicines, falsified medicines, feature, packaging, pharma

In a world living in the shadow of substandard and falsified medicines, climate change and antimicrobial resistance, pharmaceutical packaging will …
Feature

Nanovax’s seasonal flu vaccine meets Phase 3 endpoints and matches Sanofi’s Fluzone

March 24, 2020 Manufacturing and Production, Research and Development NanoFlu, Nanovax, influenza, pharma

Nanovax has reported positive Phase 3 data for its vaccine NanoFlu, with the candidate meeting its primary endpoints in the …
News

China approves Takeda’s treatment for ulcerative colitis and Crohn’s disease

March 24, 2020 Manufacturing and Production Crohn's, Takeda, Takeda China

China’s National Medical Products Administration (NMPA) has approved Takeda’s Entyvio (vedolizumab) for the treatment of adult patients with ulcerative colitis …
News
shutter

COVID-19: Gilead freezes compassionate access to remdesivir due to “overwhelming demand”, BMS and Lilly delay new study launches

March 24, 2020 Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, Eli Lilly, Gilead, Roche, cornavirus, pharma

As national governments continue to ramp up measures to contain the ongoing COVID-19 coronavirus outbreak, so too are pharma and …
News
30562517863_f4ff8e801a_b_1

UK begins lockdown as government announce tough measures to stop the spread of COVID-19

March 24, 2020 Manufacturing and Production COVID-19, Chinese Coronavirus, Wuhan Coronavirus, coronavirus, coronavirus pandemic, global pandemic

Last night, British Prime Minister Boris Johnson announced sweeping measures to bring Britain into a near total societal lockdown in …
News
7424861282_ee152c7c60_b

US continues sanctions against Iran despite coronavirus ravaging both nations

March 23, 2020 Manufacturing and Production, Sales and Marketing Iran, Iran US, US, coronavirus

The Trump administration is not relaxing sanctions on Iran, despite the country having one of the highest death tolls from …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus

The COVID-19 coronavirus continues to dominate the news: A flu drug has appeared to be effective in treating COVID-19 while …
News
science_nhmrc-grant-annoucement_180824_-_pic_1

New findings on influenza could help improve cancer treatments

March 20, 2020 Manufacturing and Production, Medical Communications Cancer, cancer treatments, flu, flu treatments, influenza

A new study into how the body fights influenza could help improve cancer immunotherapies. Researchers at the Fox Chase Cancer …
News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026